Benzofuran derivatives as anticancer inhibitors of mTOR signaling

Eur J Med Chem. 2014 Jun 23:81:181-91. doi: 10.1016/j.ejmech.2014.05.014. Epub 2014 May 5.

Abstract

A series of 32 derivatives and isosteres of the mTOR inhibitor 2 were synthesized and compared for their cytotoxicity in radioresistant SQ20B cancer cell line. Several of these compounds, in particular 30b, were significantly more cytotoxic than 2. Importantly, 30b was shown to block both mTORC1 and Akt signaling, suggesting insensitivity to the resistance associated to Akt overactivation observed with rapamycin derivatives currently used in clinic.

Keywords: Benzofuran; Cancer; Cytotoxicity; Rapamycin; mTOR.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Benzofurans / chemistry*
  • Benzofurans / pharmacology*
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Dose-Response Relationship, Drug
  • Drug Screening Assays, Antitumor
  • HCT116 Cells
  • HT29 Cells
  • Humans
  • Molecular Structure
  • Signal Transduction / drug effects*
  • Structure-Activity Relationship
  • TOR Serine-Threonine Kinases / antagonists & inhibitors*
  • TOR Serine-Threonine Kinases / metabolism

Substances

  • Antineoplastic Agents
  • Benzofurans
  • MTOR protein, human
  • TOR Serine-Threonine Kinases
  • benzofuran